The activity of platinum drugs seems not to be limited only to the triple negative BRCA1 and BRCA2 mutated tumors, but also to the sporadic TN tumors that harbor DDR deficiency. Here, BRCA1 is linked to hyperinsulinemic hypoglycemia, familial, 4.